Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Attention Theragenics Corp. Shareholders.


ATLANTA--(BUSINESS WIRE)--Jan. 21, 1999--Chitwood & Harley filed a securities class action on January 21, 1999 in the United States District Court for the Northern District of Georgia The U.S. District Court for the Northern District of Georgia serves the residents of forty-six counties. These are divided up into four districts.

The Atlanta district includes: Cherokee, Clayton, Cobb, Internet Coffe Phone, Douglas, Fulton, Gwinnett, Henry, Newton, and
 on behalf of a class of persons who purchased Theragenics Corp. ("Theragenics" or "the Company")(NYSE NYSE

See: New York Stock Exchange
: TGX TGX Theragenics Corporation (stock symbol)
TGX Trajectory Generator External
) securities between January 29, 1998 and January 11, 1999, inclusive (the "Class Period").

The complaint alleges that Theragenics and two of its officers/directors violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated prom·ul·gate  
tr.v. prom·ul·gat·ed, prom·ul·gat·ing, prom·ul·gates
1. To make known (a decree, for example) by public declaration; announce officially. See Synonyms at announce.

2.
 thereunder. Specifically, the complaint alleges that during the Class Period, defendants materially misled the investing public, thereby inflating the price of Theragenics securities, by publicly issuing false and misleading statements and omitting to disclose material facts necessary to make defendants' statements not false and misleading. The false statements centered around Theragenics' business relationship with Indigo Medical, and the sales of the Company's Theraseed(R). After at least three quarters of positive statements about the Company's business and financial results, Theragenics shocked the market by announcing it had "experienced softness" in fourth quarter sales. The price of Theragenics stock plummeted almost 34% on January 11, 1999 in response to the Company's shocking news. Prior to the disclosure of this stunning news, certain defendants sold thousands of shares of Theragenics stock realizing more than $2.7 million in proceeds.

Plaintiff is represented by Chitwood & Harley, an Atlanta law firm that concentrates its practice in representing victims of securities fraud and corporate mismanagement mis·man·age  
tr.v. mis·man·aged, mis·man·ag·ing, mis·man·ag·es
To manage badly or carelessly.



mis·manage·ment n.
 as well as other complex litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
. The firm has been appointed lead counsel in several major actions pending in both federal and state courts and has been instrumental in recovering millions of dollars on behalf of investors and shareholders.

Plaintiff is also represented by Wolf Haldenstein Adler Freeman & Herz LLP LLP - Lower Layer Protocol , a full service commercial law firm consisting of more than 35 attorneys based in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 and San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. . The firm's qualifications have repeatedly received very favorable judicial recognition. Accordingly, the firm has achieved recoveries of over one billion dollars for defrauded investors and shareholders.

Any member of the proposed class who wishes to move the Court to serve as lead plaintiff of the Class must do so no later than March 16, 1999. In order to serve as lead plaintiff, you must meet certain legal requirements. If you wish to discuss this action or have any questions concerning this notice or your rights with respect to this matter, you may contact: Corey D. Holzer, (888) 873-3999 (toll free) or by e-mail at mail@classlaw.com, CHITWOOD & HARLEY, 2900 Promenade II, 1230 Peachtree Street, N.E., Atlanta, Georgia 30309. Please visit our website at www.classlaw.com. You may also contact Wolf Haldenstein at (800) 575-0735 (Fred T. Isquith, Esq. or Shane T. Rowley, Esq.) or via e-mail at classmember@whafh.com.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 21, 1999
Words:470
Previous Article:Brookline Bancorp Announces Fourth Quarter Earnings and Dividend Declaration.
Next Article:Frontier Communications Showcases College Basketball Award Candidates on CBS Sports.
Topics:



Related Articles
Theragenics Corporation Reports Record Revenue and Earnings for Year End 1998.
Stull, Stull & Brody Announce Class Action Filed Against Theragenics Corp. on Behalf of Shareholders Who Purchased TGX Stock Between January 29, 1998...
Wolf Haldenstein Files Class Action Against Theragenics Corp.
Weiss & Yourman Announces Class Action Against Theragenics on Behalf of Theragenics Shareholders.
Wechsler Harwood Announces Class Action Against Theragenics Corp.
Stull, Stull & Brody Announce Class Action Filed Against Theragenics Corp. on Behalf of Shareholders Who Purchased TGX Stock Between January 29, 1998...
Attention Theragenics Corp. Shareholders.
Spector & Roseman, P.C. Announces Class Action Law Suit Filed Against Theragenics Corp. and Certain Officers and Directors On Behalf of All...
Class Action Against Theragenics Corp. and Certain of Its Officers and Directors Alleging Violations of Federal Securities Law.
Rabin & Peckel Makes Announcement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles